Down 6.09% pre-market: MOLN.SW Molecular Partners AG (SIX) 23 Feb 2026, catalysts
MOLN.SW stock opened pre-market among the top losers on the SIX on 23 Feb 2026 after a 1‑day decline of 6.09%, with the share trading near CHF 3.94 on light volume. Investors are flagging near-term clinical readouts and partnership updates as drivers. Molecular Partners AG (MOLN.SW) is a clinical‑stage biotech based in Switzerland; key ratios show EPS -1.62 and PB 1.45, which frame valuation debates this session.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
